about
Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses.Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.Catheter salvage in home infusion patients with central line-associated bloodstream infection.Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation.Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospitalRisk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.Environmental transmission of Clostridium difficile: association between hospital room size and C. difficile InfectionBoth host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles.Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureusUse of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery.The Antimicrobial Scrub Contamination and Transmission (ASCOT) Trial: A Three-Arm, Blinded, Randomized Controlled Trial With Crossover Design to Determine the Efficacy of Antimicrobial-Impregnated Scrubs in Preventing Healthcare Provider ContaminatiThe Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.Associations Between Different Sedatives and Ventilator-Associated Events, Length of Stay, and Mortality in Patients Who Were Mechanically Ventilated.Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.Contact patterns during cleaning of vomitus: A simulation study.Assessment of Self-Contamination During Removal of Personal Protective Equipment for Ebola Patient Care.Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.An Evaluation of Antibiotic Prescribing Practices Upon Hospital Discharge.Using a Human Factors Engineering Approach to Improve Patient Room Cleaning and Disinfection.Hand Hygiene Compliance in the Setting of Trauma Resuscitation.Medicare claims can be used to identify US hospitals with higher rates of surgical site infection following vascular surgery.Targeted versus universal decolonization to prevent ICU infection.Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices.Objective surveillance definitions for ventilator-associated pneumonia.Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance.National Healthcare Safety Network laboratory-identified Clostridium difficile event reporting: A need for diagnostic stewardship.Rapid and reproducible surveillance for ventilator-associated pneumonia.Continuous room decontamination technologies.
P50
Q33693904-888FEDE8-AA3D-4573-BED7-075B53605861Q34596560-3E6FE775-C5E7-4B46-8484-051CE73A7487Q34628499-E5BE7AFB-B5F8-48CD-AE2C-26ACA7D842EEQ34708359-0B965A8F-7BD3-47EB-9EA7-34CFDFEA25BBQ34714498-38FF4B2C-84EE-46BC-9B70-AE98AE9A8B30Q35432703-F42EECE4-EF2C-4DD0-9463-6149708DD84AQ35471522-B5D52183-A88A-483F-B772-EEE771484174Q35977404-0A1A3301-474B-4D4D-B9F3-BDB0C2076450Q36328810-F5B1CB08-C486-4C4D-8A24-3E2A8688B255Q37520201-B140DBC7-F524-4ACC-A94D-8E6C0F467C4AQ37968904-82853729-9F70-4649-B5B9-AF99122FF124Q38371593-25ED2D8C-7C43-4331-87A0-298A98CED0F7Q38389517-D3E0EC37-A14A-4EEB-ACBC-B5A9AB63F537Q38411690-A8611E5F-51CA-4F65-9222-785E3FB5E29CQ38784666-B7A0FA91-D227-4BA0-B465-6D16DDF5364EQ40078525-AF50863D-E937-4299-A257-FB0BA8FC8693Q40094628-675C3C6B-0F42-4B42-826D-E0DA8DC21CC8Q40365172-5260223F-15F8-44F1-A8D2-A00EFDA1412DQ40434675-DBDDA2A3-8725-4F94-82BE-B13FBA359DAEQ40528217-E027BBF3-D92A-4CBC-A0FB-F0A1D3EF8CD3Q40560627-A873CE65-1B52-4EC8-AF94-7C391AA460E9Q41755869-FEC03581-3E49-492D-8A82-452A7E571A7FQ42261212-02610C90-3431-4A2D-A179-6C8520741480Q47734170-1E5BD2DF-5ACA-45CD-976C-62DA7B6BC892Q48609407-8262FC1F-81B5-451D-A857-C1C980E231EEQ48690864-ED5AA45E-4FF1-4B92-8298-349B05166E19Q50159572-E3336971-5DEE-418F-91B3-1B381A7F3681Q50975477-E683751F-B517-40A2-8C7A-5F382D553E37Q64993483-A0164110-39BB-4740-88A4-0880BA36F458
P50
name
CDC Prevention Epicenters Program
@en
type
label
CDC Prevention Epicenters Program
@en
prefLabel
CDC Prevention Epicenters Program
@en